The role of the TOB1 gene in growth suppression of hepatocellular carcinoma

Oncology Letters

Volumn 4, Issue 5, 2012, Pages 981-987

  Lin, Sheyu ^a,c   Zhu, Qingfeng ^a   Xu, Yang ^a   Liu, Hui ^b   Zhang, Junyu ^a   Xu, Jiawei ^a   Wang, Honglian ^a   Sang, Qing ^a   Xing, Qinghe ^a   Fan, Jia ^a  

^a FUDAN UNIVERSITY   (China)

^b ZHENGZHOU UNIVERSITY   (China)

^c NANTONG UNIVERSITY   (China)

Author keywords

Hepatocellular carcinoma; TOB1; Tumor suppressor gene

Indexed keywords

5 AZA 2' DEOXYCYTIDINE; MESSENGER RNA;

ADULT; ARTICLE; BREAST CANCER; CANCER GROWTH; CANCER INHIBITION; CANCER SURVIVAL; CLINICAL ARTICLE; CONTROLLED STUDY; CPG ISLAND; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; LIVER CELL CARCINOMA; MALE; METHYLATION; OVERALL SURVIVAL; PROMOTER REGION; TOB1 GENE; TUMOR CELL LINE; TUMOR SUPPRESSOR GENE;

EID: 84866131305     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2012.864     Document Type: Article

References (24)

1. Maekawa M, Nishida E and Tanoue T: Identification of the anti-proliferative protein Tob as a MAPK substrate. J Biol Chem 277: 37783-37787, 2002.
2. Yoshida Y, Hosoda E, Nakamura T and Yamamoto T: Association of ANA, a member of the antiproliferative Tob family proteins, with a Caf1 component of the CCR4 transcriptional regulatory complex. Jpn J Cancer Res 92: 592-596, 2001.
3. Fletcher BS, Lim RW, Varnum BC, Kujubu DA, Koski RA and Herschman HR: Structure and expression of TIS21, a primary response gene induced by growth factors and tumor promoters. J Biol Chem 266: 14511-14518, 1991.
4. Tzachanis D, Freeman GJ, Hirano N, et al: Tob is a negative regulator of activation that is expressed in anergic and quiescent T cells. Nat Immunol 2: 1174-1182, 2001.
5. Rouault JP, Rimokh R, Tessa C, et al: BTG1, a member of a new family of antiproliferative genes. EMBO J 11: 1663-1670, 1992.
6. Rouault JP, Falette N, Guehenneux F, et al: Identification of BTG2, an antiproliferative p53-dependent component of the DNA damage cellular response pathway. Nat Genet 14: 482-486, 1996.
7. Bradbury A, Possenti R, Shooter EM and Tirone F: Molecular cloning of PC3, a putatively secreted protein whose mRNA is induced by nerve growth factor and depolarization. Proc Natl Acad Sci USA 88: 3353-3357, 1991.
8. Maekawa M, Yamamoto T and Nishida E: Regulation of subcellular localization of the antiproliferative protein Tob by its nuclear export signal and bipartite nuclear localization signal sequences. Exp Cell Res 295: 59-65, 2004.
9. Suzuki T, K-Tsuzuku J, Ajima R, Nakamura T, Yoshida Y and YamamotoT: Phosphorylation of three regulatory serines of Tob by Erk1 and Erk2 is required for Ras-mediated cell proliferation and transformation. Genes Dev 16: 1356-1370, 2002.
10. Kawamura-Tsuzuku J, Suzuki T, Yoshida Y and Yamamoto T: Nuclear localization of Tob is important for regulation of its antiproliferative activity. Oncogene 23: 6630-6638, 2004.
11. Matsuda S, Kawamura-Tsuzuku J, Ohsugi M, et al: Tob, a novel protein that interacts with p185erbB2, is associated with anti-proliferative activity. Oncogene 12: 705-713, 1996.
12. O'Malley S, Su H, Zhang T, Ng C, Ge H and Tang CK: TOB suppresses breast cancer tumorigenesis. Int J Cancer 125: 1805-1813, 2009.
13. Iwanaga K, Sueoka N, Sato A, et al: Alteration of expression or phosphorylation status of tob, a novel tumor suppressor gene product, is an early event in lung cancer. Cancer Lett 202: 71-79, 2003.
14. Yoshida Y, Tanaka S, Umemori H, et al: Negative regulation of BMP/Smad signaling by Tob in osteoblasts. Cell 103: 1085-1097, 2000.
15. Yoshida Y, von Bubnoff A, Ikematsu N, et al: Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling. Mech Dev 120: 629-637, 2003.
16. Xiong B, Rui Y, Zhang M, et al: Tob1 controls dorsal development of zebrafish embryos by antagonizing maternal beta-catenin transcriptional activity. Dev Cell 11: 225-238, 2006.
17. Ezzeddine N, Chang TC, Zhu W, et al: Human TOB, an antiproliferative transcription factor, is a poly(A)-binding protein-dependent positive regulator of cytoplasmic mRNA deadenylation. Mol Cell Biol 27: 7791-7801, 2007.
18. Yoshida Y, Nakamura T, Komoda M, et al: Mice lacking a transcriptional corepressor Tob are predisposed to cancer. Genes Dev 17: 1201-1206, 2003.
19. Liu H, Kong Q, Li B, He Y, Li P and Jia B: Expression of PEBP4 protein correlates with the invasion and metastasis of colorectal cancer. Tumour Biol 33: 267-273, 2012.
20. Gao Q, Qiu SJ, Fan J, et al: Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25: 2586-2593, 2007.
21. Zhao Y, Kong X, Li X, et al: Metadherin mediates lipopolysaccharide-induced migration and invasion of breast cancer cells. PLoS One 6: e29363, 2011.
22. Llovet JM, Di Bisceglie AM, Bruix J, et al: Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst100: 698-711, 2008.
23. Tost J: DNA methylation: an introduction to the biology and the disease-associated changes of a promising biomarker. Mol Biotechnol 44: 71-81, 2010.
24. Ruan L, Osawa M, Hosoda N, et al: Quantitative characterization of Tob interactions provides the thermodynamic basis for translation termination-coupled deadenylase regulation. J Biol Chem 285: 27624-27631, 2010.